End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.54 CNY | +3.66% | +12.49% | -21.36% |
Business Summary
Number of employees: 1,961
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug
98.4
%
| 2,342 | 98.6 % | 2,417 | 98.4 % | +3.17% |
Promotional Services
0.9
%
| 19 | 0.8 % | 22 | 0.9 % | +15.37% |
Factory Rental
0.7
%
| 14 | 0.6 % | 16 | 0.7 % | +11.48% |
Others
0.0
%
| 0 | 0.0 % | 1 | 0.0 % | +126.44% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 2,376 | 100.0 % | 2,455 | 100.0 % | +3.32% |
Abroad
0.0
%
| 0 | 0.0 % | 1 | 0.0 % | +126.04% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jia Tong
CEO | Chief Executive Officer | 46 | 02-12-31 |
Lie Ming Ding
CEO | Chief Executive Officer | 60 | 03-01-06 |
Jian Xun Fan
DFI | Director of Finance/CFO | 53 | 15-12-31 |
Jiang Wan
COO | Chief Operating Officer | 56 | 11-03-31 |
Jia Bing Wang
CTO | Chief Tech/Sci/R&D Officer | 60 | 16-02-27 |
Jian Hao Shen
IRC | Investor Relations Contact | - | - |
Ling Xi Wu
SEC | Corporate Secretary | 41 | 20-09-23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lie Ming Ding
CEO | Chief Executive Officer | 60 | 03-01-06 |
Wei Wang
BRD | Director/Board Member | 57 | 19-11-21 |
Jiang Nan Cai
BRD | Director/Board Member | 67 | 19-11-21 |
Jia Bing Wang
CTO | Chief Tech/Sci/R&D Officer | 60 | 16-02-27 |
Zhi Hua Yu
BRD | Director/Board Member | 56 | 17-09-05 |
Jiang Wan
COO | Chief Operating Officer | 56 | 11-03-31 |
Yang Nan Zhang
CHM | Chairman | 52 | 18-11-21 |
Jian Xun Fan
DFI | Director of Finance/CFO | 53 | 15-12-31 |
Tian Xu
BRD | Director/Board Member | 62 | 22-10-16 |
Xin Qi Huang
BRD | Director/Board Member | 53 | 21-01-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 418,485,885 | 215,716,338 ( 51.55 %) | 0 | 51.55 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
C4 THERAPEUTICS, INC. 8.12% | 5,567,928 | 8.12% | 45,489,972 $ |
Company contact information
Betta Pharmaceuticals Co., Ltd.
355 Xingzhong Road Yuhang Economic & Tech Dev Zone
311100, Hangzhou
+
http://www.bettapharma.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.36% | 2.34B | |
+5.31% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
-29.67% | 2.2B | |
+8.38% | 1.96B | |
+3.90% | 1.65B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 300558 Stock
- Company Betta Pharmaceuticals Co., Ltd.